ADD CONDITION

items per page

Uva Ursi

Last content change checked dailysee data sync status

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient
Arctostaphylos Uva-Ursi Leaf 6 [hp_C]/6 [hp_C]
Dosage form
Pellet
Route
Oral
Prescription status
Homeopathic
Marketed in the U.S.
Since 1983
Label revision date
November 15, 2023
Active ingredient
Arctostaphylos Uva-Ursi Leaf 6 [hp_C]/6 [hp_C]
Dosage form
Pellet
Route
Oral
Prescription status
Homeopathic
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 1983
Label revision date
November 15, 2023
Manufacturer
Boiron
NDC root
0220-5161

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that the information provided does not include specific details about the drug's name, general description, or its mechanism of action. However, based on the context, it appears that the drug may be related to addressing abdominal cramps during urination.

If you are experiencing abdominal cramps while urinating, it is important to consult with a healthcare professional for proper evaluation and treatment options. They can provide you with the necessary information about medications that may help alleviate your symptoms and improve your comfort.

Uses

If you're experiencing abdominal cramps during urination, this medication may be used to help alleviate that discomfort. It's important to note that there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication. Always consult with your healthcare provider for personalized advice and to ensure this treatment is right for you.

Dosage and Administration

When you first notice symptoms, take 5 pellets of the medication and let them dissolve under your tongue. You should do this three times a day. Continue this routine until your symptoms improve or follow your doctor's specific instructions. This method helps ensure that the medication is absorbed effectively into your system.

Warnings and Precautions

It's important to be aware of certain precautions while using this medication. If your symptoms last longer than three days or worsen, you should stop taking the medication and contact your doctor for further guidance.

Currently, there are no specific warnings or emergency instructions provided for this medication. However, always stay alert to how you feel and seek medical advice if you have any concerns.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely action can make a significant difference.

Storage and Handling

It's important to store this product safely by keeping it out of reach of children to prevent any accidental ingestion or misuse. When handling the device, ensure that you do not use it if the seal on the pellet dispenser is broken, as this could compromise its safety and effectiveness.

Always check the packaging before use to ensure everything is intact. Following these simple guidelines will help you use the product safely and effectively.

Additional Information

You should take this medication orally. For both adults and children, dissolve 5 pellets under your tongue three times a day at the onset of symptoms, continuing until symptoms improve or as directed by your doctor.

If your symptoms last more than three days or worsen, stop using the medication and consult your doctor. If you are pregnant or breastfeeding, it's important to speak with a healthcare professional before using this product. Always keep it out of reach of children and do not use it if the pellet dispenser seal is broken.

FAQ

What should I do if I experience abdominal cramps during urination?

You can dissolve 5 pellets under your tongue 3 times a day at the onset of symptoms until they are relieved or as directed by a doctor.

Are there any teratogenic effects associated with this drug?

No teratogenic effects have been mentioned for this drug.

What should I do if my symptoms persist or worsen?

You should stop using the drug and ask a doctor if symptoms persist for more than 3 days or worsen.

Is this drug safe for children?

Yes, the same dosage instructions apply to both adults and children.

What precautions should I take when using this drug?

Keep the drug out of reach of children and do not use it if the pellet dispenser seal is broken.

Should I consult a doctor if I am pregnant or breastfeeding?

Yes, you should ask a health professional before use if you are pregnant or breastfeeding.

Packaging Info

This section summarizes the homeopathic presentations of Uva Ursi (arctostaphylos uva-ursi leaf). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.
Details

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

UVA URSI is a homeopathic medicinal product containing Arctostaphylos uva-ursi leaf as the active ingredient, with a strength of 6 hp_C. Each pellet contains 0.443 mg of the active ingredient. The product is formulated with inactive ingredients including sucrose (UNII: C151H8M554) and unspecified form of lactose (UNII: J2B2A4N98G).

UVA URSI pellets are characterized by their white color, round shape, and a size of 4 mm. The product is packaged in a tube containing 6 pellets, classified as Type 0: Not a Combination Product, with the item code NDC: 0220-5161-41. The marketing start date for this product is March 3, 1983. The labeler and registrant for UVA URSI is Boiron, Inc. (Labeler Code: 282560473, Registrant Code: 014892269).

Packaging & NDC

This section summarizes the homeopathic presentations of Uva Ursi (arctostaphylos uva-ursi leaf). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.
Details

Manufacturer Insert (PDF)

This is the product document submitted by Boiron for Uva Ursi. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Uva Ursi, retrieved by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.